| LAVIOLLE, Bruno |
| Suspended | 2/3 | 40 | Europe | Fludrocortisone, Flucortac, Placebo | Rennes University Hospital, H.A.C. PHARMA | Septic Shock | 06/24 | 12/24 | | |
DIPLOID, NCT04489134: P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release |
|
|
| Completed | 2 | 27 | Europe | Treatment A, Treatment B, Treament C, Treatment D, Pharmacocinetik, Genetic, Selection visit: | Rennes University Hospital | Pharmacokinetics | 05/23 | 05/23 | | |
| LAINE, Fabrice |
CoviCompare_J, NCT05037266: Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen |
|
|
| Active, not recruiting | 4 | 27 | Europe | COVID-19 Vaccine Janssen (Ad26.COV2-S) | Centre Hospitalier Universitaire de Saint Etienne | Healthy Volunteers | 02/22 | 12/24 | | |
| Recruiting | 2 | 318 | Europe | NFL-101 dose 1, Tobacco leaf extract, NFL-101 dose 2, Placebo, WFI | NFL Biosciences SAS | Smoking Cessation, Nicotine Dependence | 07/24 | 12/24 | | |
| Recruiting | N/A | 480 | Europe | Bone densitometry (BMD), Blood sampling for patients only | Centre Hospitalier Universitaire de Saint Etienne, Ministry of Health, France | Hemophilia | 12/24 | 03/25 | | |
CAP'Hospi, NCT05380193: Serotype Distribution in Hospitalized Adult with Pneumococcal Community Acquired Pneumonia in France |
|
|
| Active, not recruiting | N/A | 2000 | Europe | | Institut National de la Santé Et de la Recherche Médicale, France | Pneumonia, Pneumococcal Infections, Community-acquired Pneumonia | 02/25 | 02/25 | | |
RESPIVAC, NCT05582239: Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults |
|
|
| Recruiting | N/A | 2400 | Europe | | ANRS, Emerging Infectious Diseases, P95, I-REIVAC, EPICONCEPT, Institut de Recherche en Santé Publique, France | Severe Acute Respiratory Infection (SARI), Influenza, COVID-19 | 01/26 | 01/26 | | |
